Navigation Links
Trade Center Collapse Caused Lung Ailments in Rescuers

This is perhaps the first clinical study that relates the collapse of the trade center to lung ailments in the rescuers, due to inhalation of dust and pollutants during the rescue operation. The rescuers seem to be suffering a rare type of lung condition which showed up a year after the catastrophe.

Medical specialists from the Fire Department and from the Albert Einstein College of Medicine found that 13 firefighters and emergency medical service workers were sick with sarcoidosis a serious illness where the lungs and other organs swell up to form lumps of cells, medically called as granulomas. This condition can be controlled with drugs, yet, in some cases it worsens leading to death.

A year after the collapse, statistics showed the incidence of this illness in 86 cases per 100,000 workers. Doctors also detected 26 cases of sarcoidosis in the five years after 9/11. Although there have been no deaths due to this lung condition, five are permanently disabled and another five are progressively reaching the stage.

Many federal and local studies examining the exposure to dust and pollution had shown that a majority of the recovery workers were down with severe cough and respiratory infection. This study is the most recent peer-reviewed study, and therefore is more authentic. The annual check-ups conducted by Doctors made it possible to draw a comparative study of the workers health pre and post 9/11.


Page: 1

Related medicine news :

1. Trafficking of Women from Asia and East Europe For Flesh Trade
2. China Issues New Legislation To Ban Human Organ Trade
3. Ban on Trade of Human Organs in China
4. Kidney Trade: Curbing the Sale
5. Busting the Organ Trade Racket in Tamil Nadu
6. Ukraine Struggles Against Fake Drug Trade
7. Traders Smell Something Fishy in Tokyo Market Move
8. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
9. Osaka Medical Center study showed 70% of smokers couldn’t qui
10. Kalam To Lay Foundation Of Vellore Research Center
11. Free Treatment Center Established In Chennai
Post Your Comments:

(Date:6/27/2016)... ... ... recently awarded their highest five-star rating to Best Buy Eyeglasses, an ... United States and Canada wear eyeglasses. Once considered to be a purely functional part ... fashion statement. Even celebrities use glasses as a way of creating an iconic image—like ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
Breaking Medicine Technology: